Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Dec 17, 2025
- Amount
- $500,000
- Closes
- Jan 7, 2028 (in 496 days)
Similar opportunities open now
- Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)Same funderOpenNational Institutes of HealthCloses Jan 2028Up to $500K
- Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Jan 2028
- Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Sep 2027
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses Jan 2027
- Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Nov 2027
Classification and identifiers
- Solicitation number
- PAR-24-311
- Assistance listing (CFDA)
- 93.394
Amount
$500,000
Who can apply
Private colleges and universities and Public colleges and universities can all apply here. Check the eligibility details below to see if your organization fits.
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
About this opportunity
The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo. The motivation for this initiative is that much of current imaging research into the role of inflammation in cancer is largely based on in vitro and ex vivo methods with limited utilization of imaging approaches that could lead to significant new insights relevant to dynamic cancer and inflammation interactions. Utilization of molecular imaging probes in pre-clinical and clinical investigations for precise temporal resolution at the molecular and cellular level are valuable approaches for identification and characterization of in vivo inflammatory c...